**Prenatal ultrasound diagnosis of a multiple atypical right atrial cardiac fibroma**

Colmorn LB, *et al. Ultraschall in Med* 2011; 32: 85--6

Congenital cardiac tumors are rare and prenatal diagnosis may not be made, if at all, till the third trimester. The fetus in this case report had had 13 and 22 week scans reported as normal but because of a previous preterm birth had growth and cervical length examinations until 36 weeks. These scans were also reported as normal, although the fetal heart may not have been targetted.

Diagnosis was eventually made because the sonographer noted marked ascites at the growth scan. A cardiac fibroma was diagnosed and emergency section performed. Two days later, cardiac surgery was done with tumor excisions from the right atrium.

Rhabdomyomas are the commonest cardiac tumors. Ultrasound diagnosis, while dependent on size, location, appearance and number, may not differentiate them from fibromas or teratomas. Fibromas are infiltrative and while not associated with tuberous sclerosis like rhabdomyomas, have a lower survival rate than any other cardiac tumors.

**Precise mid‐trimester placenta localization: does it predict adverse outcomes?**

Alice J Robinson, Peter R Muller, Richard Allan, Richard Ross, Peter A Baghurst, Marc JNC Kei rse

*A NZ J Obstet Gynaecol* 2012; 52: 156--60

This Australian study addressed the question of what is a low lying placenta at the mid‐trimester ultrasound, when it should be reported to the clinician and what benefits there are from follow up scans. All questions we thought we knew the answer to!

1662 pregnancies were divided into three groups -- the low lying placenta with a 0--30 mm placenta -- os distance, a control group with placenta -- os distance of 31--40 mm and a subgroup with a measurement of \> 40 mm.

Transvaginal scans were not routine and this limited the study, as did the fact that they did not collect data where the placenta overlapped the internal cervical os. Nevertheless their follow up was powerful enough to conclude that a placenta within 3cm of, but not over, the internal cervical os, does not result in significant antepartum or neonatal complications. So using this cut‐off we could reduce maternal anxiety and save resources by not labeling as high risk those placentas not overlapping the cervical os in mid‐trimester.

**Social and practical implications of fetal sex determination using ultrasound**

Edwards H and Thomson N *Ultrasound* 2012; 20: 49--53

This is a thoughtful review of this thorny subject with its moral and ethical issues. The authors point out that in many cultures in India, Nepal, China, South Korea, Vietnam, Jordan, Albania, Azerbaijan, Armenia and Georgia there is a preference for boys. And because of terminations of fetal fetuses some of these countries are recording a preponderance of male births. This is happening with some immigrant families in the USA and UK and in all likelihood in Australia too.

But ultrasound is not 100% accurate with results varying from 70--98% accuracy in the first trimester. Even at the 20 week scan one study showed 3.3% incorrectly assigned. So we should advise those who want sex determination that errors can occur.

The primary purpose of prenatal ultrasound is not finding out the sex, but most people of course do want to know.

**Sonographic breast elastography: a primer**

Barr RG *J Ultrasound Med* 2012; 31: 773--83

Breast elastography, whether strain or shear wave, provides information on the hardness of a lesion, similar to palpitation by the clinician. This detailed article reviews the basics and explains the pros and cons of the techniques. It also points out the pitfalls. There is still work to be done to standardise the techniques so that the number of benign breast biopsies can be reduced.

**Reliability of 3--Dimensional transvaginal sonographic measurement of lower uterine segment thickness**

Amélie Boutin, Nicole Jastrow, Stéphanie Roberge, Nils Chaillet, Laurie Bérubé, Normand Brassard, Mario Girard, Emmanuel Bujold

*J Ultrasound Med* 2012; 31: 933--39

This Canadian study is worth a read. There is data showing excellent reliability of 2D measurement of the lower uterine segment by the transvaginal approach. There is still debate however on the optimal threshold of lower segment thickness with measurements ranging between 2.0 and 3.5 mm.

This prospective study of 60 patients with previous low transverse Caesarean deliveries was done between 35 and 39 weeks gestation. Two dimensional scans and 3--dimension volume data sets on lower segment thickness were obtained and analysed. The intra and inter observer rates were calculated as was the inter method reliability.

The conclusion is that 3D transvaginal scans are reproducible and as reliable as 2D scans. The advantages of off‐line distant analysis and use in training is emphasised.

**The Gleaner**
